<?xml version="1.0" encoding="UTF-8"?>
<ref id="B35-pathogens-09-00519">
 <label>35.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>He</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kou</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Farzan</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: Implication for developing subunit vaccine</article-title>
  <source>Biochem. Biophys. Res. Commun.</source>
  <year>2004</year>
  <volume>324</volume>
  <fpage>773</fpage>
  <lpage>781</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bbrc.2004.09.106</pub-id>
  <?supplied-pmid 15474494?>
  <pub-id pub-id-type="pmid">15474494</pub-id>
 </element-citation>
</ref>
